A detailed history of Virtus ETF Advisers LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 7,338 shares of CABA stock, worth $20,106. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,338
Previous 7,207 1.82%
Holding current value
$20,106
Previous $53,000 35.85%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.94 - $8.24 $516 - $1,079
131 Added 1.82%
7,338 $34,000
Q2 2024

Aug 14, 2024

BUY
$7.22 - $18.82 $21,602 - $56,309
2,992 Added 70.98%
7,207 $53,000
Q1 2024

May 15, 2024

SELL
$16.79 - $25.38 $4,902 - $7,410
-292 Reduced 6.48%
4,215 $71,000
Q4 2023

Feb 15, 2024

BUY
$12.21 - $23.36 $55,030 - $105,283
4,507 New
4,507 $102,000

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $79.5M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.